Literature DB >> 26093468

Identifying the determinants of microalbuminuria in obese patients in primary care units: the effects of blood pressure, random plasma glucose and other risk factors.

E Pehlivan1, G Ozen2, H Taskapan3, G Gunes2, I Sahin3, C Colak4.   

Abstract

OBJECTIVE: The objective of this study is to evaluate the demographic characteristics, blood pressure and blood glucose and the other related factors that affect the microalbuminuria levels in the obese patients aged 40 and above who applied to the primary care for medical evaluation.
MATERIALS AND METHODS: The population of the research, which was a cross-sectional type, comprised obese patients aged 40 and above who had applied to the community health centers in the center of Malatya. A total of 422 obese patients consisting of 116 males and 306 females were included in the research. The anthropometric measurements of the participants were determined, their blood pressures and their random blood glucoses were evaluated, as well. A microalbuminuria measurement was performed in the urine samples taken from the patients using "Nycocard Reader II" device.
FINDINGS: The incidence of microalbuminuria in patients was found as 31.5%, whereas the incidence of macroalbuminuria was 6.6%. The incidence of microalbuminuria in female patients was 32.7%, while it was 28.4% in male patients; on the other hand, the incidence of macroalbuminuria in female patients was found as 6.8%, whereas this percentage was determined as 7.8 in male patients (p > 0.05). The probability of the incidence of microalbuminuria increased 2.8 times more in those with the diastolic blood pressure of 90 mmHg and above when compared to those without it (GA: 1.79-4.56), whereas the incidence increased 3.2 times more in those with the random blood glucose of 200 mg/l and above (GA: 1.32-7.84) (p < 0.001). In our study, among the variables predicting the microalbuminuria in obese patients; the cutoff values of the diastolic and systolic blood pressures, the waist circumference were found as >85 mmHg; >130 mmHg; >141 mg/dl, respectively, in male patients and found as >85 mmHg, >114 cm, and 109 cm, respectively, in female patients. The sensitivity and specificity of the tests indicating the cutoff values showed significance (p < 0.05). There was no statistically significant relevance between the microalbumin levels of the obese patients via the anthropometric criteria, except for their waist circumference (p > 0.05). RESULT: In this study, the blood pressure and blood glucose levels of the patients along with their waist circumference that indicated a central obesity were specified as the determinants of microalbuminuria. While the obese patients are being evaluated in terms of proteinuria, the cutoff values of these variables can be taken into consideration.

Entities:  

Keywords:  Diabetes; Hypertension; Microalbuminuria; Obesity; Primary care

Mesh:

Substances:

Year:  2015        PMID: 26093468     DOI: 10.1007/s40618-015-0331-6

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  24 in total

Review 1.  Microalbuminuria as a predictor of clinical diabetic nephropathy.

Authors:  C E Mogensen
Journal:  Kidney Int       Date:  1987-02       Impact factor: 10.612

2.  Obesity-related glomerulopathy: insights from gene expression profiles of the glomeruli derived from renal biopsy samples.

Authors:  Yichao Wu; Zhihong Liu; Zhaoying Xiang; Caihong Zeng; Zhaohong Chen; Xiaojing Ma; Leishi Li
Journal:  Endocrinology       Date:  2005-10-06       Impact factor: 4.736

3.  Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

Authors:  H C Gerstein; J F Mann; Q Yi; B Zinman; S F Dinneen; B Hoogwerf; J P Hallé; J Young; A Rashkow; C Joyce; S Nawaz; S Yusuf
Journal:  JAMA       Date:  2001-07-25       Impact factor: 56.272

4.  Prevalence of microalbuminuria in type 2 diabetes mellitus at a diabetes centre in southern India.

Authors:  A Varghese; R Deepa; M Rema; V Mohan
Journal:  Postgrad Med J       Date:  2001-06       Impact factor: 2.401

5.  Microalbuminuria in obese patients with or without hypertension.

Authors:  P Valensi; M Assayag; M Busby; J Pariès; B Lormeau; J R Attali
Journal:  Int J Obes Relat Metab Disord       Date:  1996-06

6.  MicroAlbuminuria Prevalence Study (MAPS) in hypertensive type 2 diabetic patients in Hong Kong.

Authors:  V T F Yeung; K F Lee; S H Chan; L F Ho; S K Leung; H Y Wong
Journal:  Hong Kong Med J       Date:  2006-06       Impact factor: 2.227

7.  Racial and ethnic differences in microalbuminuria prevalence in a diabetes population: the pathways study.

Authors:  Bessie A Young; Wayne J Katon; Michael Von Korff; Greg E Simon; Elizabeth H B Lin; Paul S Ciechanowski; Terry Bush; Malia Oliver; Evette J Ludman; Edward J Boyko
Journal:  J Am Soc Nephrol       Date:  2004-11-24       Impact factor: 10.121

8.  Microalbuminuria prevalence study in hypertensive patients with type 2 diabetes in Pakistan.

Authors:  Muhammad Yakoob Ahmadani; Asher Fawwad; Abdul Basit; Zafar Iqbal Hydrie
Journal:  J Ayub Med Coll Abbottabad       Date:  2008 Jul-Sep

9.  Diabetes care in remote northern Australian Indigenous communities.

Authors:  Robyn A McDermott; Fiona Tulip; Barbara Schmidt
Journal:  Med J Aust       Date:  2004-05-17       Impact factor: 7.738

10.  [The relationship of microalbuminuria with left ventricular functions and silent myocardial ischemia in asymptomatic patients with type 2 diabetes].

Authors:  Ozlem Yildirimtürk; Mehtap Kiliçgedik; Aylin Tuğcu; Vedat Aytekin; Saide Aytekin
Journal:  Turk Kardiyol Dern Ars       Date:  2009-03
View more
  4 in total

Review 1.  Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis.

Authors:  Vivette D D'Agati; Avry Chagnac; Aiko P J de Vries; Moshe Levi; Esteban Porrini; Michal Herman-Edelstein; Manuel Praga
Journal:  Nat Rev Nephrol       Date:  2016-06-06       Impact factor: 28.314

2.  Glycated Hemoglobin is Independently Associated with Albuminuria in Young Nondiabetic People with Obesity: A Cross-Sectional Study.

Authors:  Yanli Li; Juan Shi; Xiaolin Huang; Rui Wang; Bin Gu; Peiwen Liang; Shaoqian Zhao; Yingkai Sun; Wen Liu; Yuying Deng; Liuqing Xi; Dandan Zhao; Dalong Song; Yanan Cao; Yifei Zhang; Weiqiong Gu; Jie Hong
Journal:  Med Sci Monit       Date:  2017-05-29

3.  Association between thyroid function and diabetic nephropathy in euthyroid subjects with type 2 diabetes mellitus: a cross-sectional study in China.

Authors:  Jian Wang; Huiqin Li; Mingjuan Tan; Gu Gao; Ying Zhang; Bo Ding; Xiaofei Su; Xiaocen Kong; Jianhua Ma
Journal:  Oncotarget       Date:  2019-01-04

4.  Probiotics ameliorates glycemic control of patients with diabetic nephropathy: A randomized clinical study.

Authors:  Hongyang Jiang; Yan Zhang; Dongyan Xu; Qing Wang
Journal:  J Clin Lab Anal       Date:  2021-03-05       Impact factor: 2.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.